Emilie K. Johnson

Emilie K. Johnson

Auto-generated profile, based on publicly available information

Emilie K. Johnson

Division of Urology, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Journal of Adolescent Health
Verified
Journal Article
Closed access
DCDiane Chen
Diane Chen
LSLisa Simons
Lisa Simons
EJEmilie K. Johnson
Emilie K. Johnson
BLBarbara A. Lockart
Barbara A. Lockart
CFCourtney Finlayson
Courtney Finlayson

1 July 2013 in Journal of Urology
Verified
Journal Article
Closed access
EJEmilie K. Johnson
Emilie K. Johnson
CNCaleb P. Nelson
Caleb P. Nelson

1 July 2018 in Journal of Adolescent Health
Verified
Journal Article
Closed access
DCDiane Chen
Diane Chen
MMMargaret Matson
Margaret Matson
KMKathryn Macapagal
Kathryn Macapagal
EJEmilie K. Johnson
Emilie K. Johnson
IRIlina Rosoklija
Ilina Rosoklija
BMBrian Mustanski
Brian Mustanski

1 September 2008 in Urology
Verified
Journal Article
Closed access
EJEmilie K. Johnson
Emilie K. Johnson
SDStephanie Daignault
Stephanie Daignault
YZYingxi Zhang
Yingxi Zhang
CLCheryl T. Lee
Cheryl T. Lee

1 April 2014 in Journal of Urology
Verified
Journal Article
Closed access
BVBriony K. Varda
Briony K. Varda
EJEmilie K. Johnson
Emilie K. Johnson
CCCurtis Clark
Curtis Clark
BCBenjamin I. Chung
Benjamin I. Chung
CNCaleb P. Nelson
Caleb P. Nelson
SCSteven L. Chang
Steven L. Chang
We performed a population based study comparing trends in perioperative outcomes and costs for open, laparoscopic and robotic pediatric pyeloplasty. Specific billing items contributing to cost were also investigated. Using the Perspective database (Premier, Inc., Charlotte, North Carolina), we identified 12,662 pediatric patients who underwent open, laparoscopic and robotic pyeloplasty (ICD-9 55.87) in the United States from 2003 to 2010. Univariate and multivariate statistics were used to evaluate perioperative outcomes, complications and costs for the competing surgical approaches. Propensity weighting was used to minimize selection bias. Sampling weights were used to yield a nationally representative sample. A decrease in open pyeloplasty and an increase in minimally invasive pyeloplasty were observed. All procedures had low complication rates. Compared to open pyeloplasty, laparoscopic and robotic pyeloplasty had longer median operative times (240 minutes, p <0.0001 and 270 minutes, p <0.0001, respectively). There was no difference in median length of stay. Median total cost was lower among patients undergoing open vs robotic pyeloplasty ($7,221 vs $10,780, p <0.001). This cost difference was largely attributable to robotic supply costs. During the study period open pyeloplasty made up a declining majority of cases. Use of laparoscopic pyeloplasty plateaued, while robotic pyeloplasty increased. Operative time was longer for minimally invasive pyeloplasty, while length of stay was equivalent across all procedures. A higher cost associated with robotic pyeloplasty was driven by operating room use and robotic equipment costs, which nullified low room and board cost. This study reflects an adoption period for robotic pyeloplasty. With time, perioperative outcomes and cost may improve.

1 March 2014 in Pediatrics
Verified
Journal Article
Closed access
CNCaleb P. Nelson
Caleb P. Nelson
EJEmilie K. Johnson
Emilie K. Johnson
TLTanya Logvinenko
Tanya Logvinenko
JCJeanne S. Chow
Jeanne S. Chow
BACKGROUND: The 2011 American Academy of Pediatrics guidelines state that renal and bladder ultrasound (RBUS) should be performed after initial febrile urinary tract infection (UTI) in a young child, with voiding cystourethrogram (VCUG) performed only if RBUS shows abnormalities. We sought to determine test characteristics and predictive values of RBUS for VCUG findings in this setting. METHODS: We analyzed 3995 clinical encounters from January 1, 2006 to December 31, 2010 during which VCUG and RBUS were performed for history of UTI. Patients who had previous postnatal genitourinary imaging or history of prenatal hydronephrosis were excluded. Sensitivity, specificity, and predictive values of RBUS for VCUG abnormalities were determined. RESULTS: We identified 2259 patients age II in 20.9%, and VUR grade >III in 2.8%. Sensitivity of RBUS for any abnormal findings on VCUG ranged from 5% (specificity: 97%) to 28% (specificity: 77%). Sensitivity for VUR grade >III ranged from 18% (specificity: 97%) to 55% (specificity: 77%). Among the 1203 children aged 2 to 24 months imaged after a first febrile UTI, positive predictive value of RBUS was 37% to 47% for VUR grade >II (13% to 24% for VUR grade >III); negative predictive value was 72% to 74% for VUR grade >II (95% to 96% for VUR grade >III). CONCLUSIONS: RBUS is a poor screening test for genitourinary abnormalities. RBUS and VCUG should be considered complementary as they provide important, but different, information.